| Product NDC: | 50436-3621 |
| Proprietary Name: | Voltaren |
| Non Proprietary Name: | diclofenac sodium |
| Active Ingredient(s): | 10 mg/g & nbsp; diclofenac sodium |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 50436-3621 |
| Labeler Name: | Unit Dose Services |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022122 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20071017 |
| Package NDC: | 50436-3621-1 |
| Package Description: | 1 TUBE in 1 CARTON (50436-3621-1) > 100 g in 1 TUBE |
| NDC Code | 50436-3621-1 |
| Proprietary Name | Voltaren |
| Package Description | 1 TUBE in 1 CARTON (50436-3621-1) > 100 g in 1 TUBE |
| Product NDC | 50436-3621 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | diclofenac sodium |
| Dosage Form Name | GEL |
| Route Name | TOPICAL |
| Start Marketing Date | 20071017 |
| Marketing Category Name | NDA |
| Labeler Name | Unit Dose Services |
| Substance Name | DICLOFENAC SODIUM |
| Strength Number | 10 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |